BIOMEDevice Silicon Valley 2026 Event: The Full Guide to What It Is, Who Attends, and Why It Matters

What the BIOMEDevice Silicon Valley 2026 Event Actually Is

The BIOMEDevice Silicon Valley 2026 event is the Bay Area edition of Informa Markets' medical device manufacturing show portfolio. It's a two-day expo and conference held annually in November at the Santa Clara Convention Center, focused on connecting OEMs, contract manufacturers, component suppliers, regulatory consultants, and emerging medtech startups across digital health, AI medtech, connected health, additive manufacturing, and diagnostics.

Concretely, the 2026 event is built around three things: a 150+ exhibitor expo floor, a 20+ hour education program across five tracks, and an Innovation Showcase that highlights early-stage Bay Area medtech companies. It draws roughly 1,200 attendees, small by Informa Markets standards (MD&M West runs ~7,000), but tightly targeted at the engineering and product side of medtech rather than the broader supply-chain audience of the larger shows.

If you're trying to figure out whether the event is worth a flight to Santa Clara, the short answer depends on what you build and who you sell to. The Bay Area medtech crowd is concentrated, technical, and skeptical of generic pitches, high signal if your buyer is here, low signal if your buyers are health systems, clinicians, or high-volume contract manufacturing programs.

The Rebrand: From BIOMEDevice to MEDevice (and Why It Matters)

The first thing to know about the 2026 event is that the name on the door has changed. Informa Markets renamed BIOMEDevice Silicon Valley to MEDevice Silicon Valley starting with the 2026 edition. The "BIO" prefix was dropped to align Santa Clara's branding with the rest of the Informa portfolio, MD&M West (Anaheim), MD&M East (New York), MD&M South (Charlotte), and MD&M Midwest (Minneapolis) all use the unified MD&M / MEDevice naming convention now.

What changed:

• The name: BIOMEDevice Silicon Valley → MEDevice Silicon Valley
• The URL: medevicesiliconvalley.com (the old biomedevice.com properties now redirect)
• The branding: Aligned visually with the MD&M family

What did not change:

• The venue: Still the Santa Clara Convention Center
• The cadence: Still November, two days, mid-week
• The audience: Same ~1,200 Bay Area-skewed medtech professionals
• The team: Same Informa Markets sales contacts and operations crew
• The exhibitor pricing: Same ~$50/sqft standard booth rate

So when historical search traffic still types "BIOMEDevice Silicon Valley 2026 event" into Google, what you're looking for is MEDevice Silicon Valley 2026. The event is real, it's happening, and the rebrand is purely a naming change.

Dates, Venue, and Format at a Glance

The two-day structure is densely packed. There's no padding day, no half-day formats, the expo floor is open during peak hours both days, and the education program runs back-to-back from morning to late afternoon. Plan for the show to consume the full Wednesday and Thursday, with travel days on either side.

Who Attends the BIOMEDevice Silicon Valley 2026 Event

The attendee mix is what makes this event different from MD&M West, FIME, or HIMSS. The Santa Clara crowd skews engineering, product, and startup-side. Specifically:

• Medtech engineers working on Class II and Class III device design
• R&D managers at established OEMs and Series-A through Series-C startups
• Product managers for digital health, connected devices, and AI-powered medtech
• Regulatory specialists navigating FDA pathways, 510(k), De Novo, and software-as-a-medical-device guidance
• Startup founders in the Bay Area medtech innovation ecosystem
• Contract manufacturing leads sourcing components, materials, and specialty services
• Investors and corporate scouts tracking emerging Bay Area medtech companies

Roughly 40% of attendees hold purchasing authority, high for a regional show, and about 10% travel from outside the US. The crowd is heavily concentrated in the Bay Area, Sacramento, and the Pacific Northwest, with secondary clusters from San Diego, Boston, and Minnesota.

If your audience is clinicians, hospital health system buyers, or high-volume CMO buyers in the orthopedics or cardiovascular implant space, this is probably not your event, you'll want the AAOS or HRS conferences for clinical buyers and MD&M West for high-volume manufacturing. For a fuller view of the trade-off, our medical conference marketing ROI playbook walks through how we triage which medtech shows are worth the spend each year.

The Five Education Tracks (And What's New for 2026)

Twenty-plus hours of education is the conference pass's main value driver. The 2026 program runs across five tracks, each with a mix of keynotes, panels, and deep-dive sessions:

1. AI medtech: FDA's evolving AI/ML guidance, model validation, real-world performance monitoring, predetermined change control plans. The fastest-growing track on the program.
2. IoT and connected health: Cellular and Bluetooth device telemetry, cybersecurity for connected devices (FDA's 2023 cyber guidance is still the reference), patient-data privacy under HIPAA and state biometric laws.
3. Additive manufacturing: 3D-printed implants, patient-specific instrumentation, FDA expectations for additive process validation.
4. Diagnostics: Point-of-care platforms, lab-developed tests, the post-VALID Act regulatory landscape.
5. Regulatory strategy: 510(k) submission strategy, De Novo pathways, software-as-a-medical-device classification, and post-market surveillance.

The AI and regulatory rooms fill fastest. If you're conference-pass eligible, build your daily schedule the night before, high-demand sessions cap room capacity, and the on-site app shifts in real time as session slots fill.

The Expo Floor: 150+ Exhibitors and the Innovation Showcase

The expo runs both days and is the main draw for expo-only attendees. The 150+ exhibitor mix typically breaks down across contract manufacturing, digital health platforms, IoT and connected device infrastructure, additive manufacturing, diagnostics components, wearable form factors, regulatory consulting firms, and software-as-a-medical-device testing services.

The Innovation Showcase, a curated area for emerging companies to show new technologies, is the highest-density part of the floor for investors and corporate scouts. If you're a Series A or Series B startup with a Showcase booth, plan your live demos for 11 AM and 2 PM on day one. That's when investor foot traffic peaks. If you're an established OEM looking for the next acquisition target or partnership, the Showcase is where you'll find them.

For the full breakdown of the exhibitor list, booth strategy, audience-quality data, and pricing details, the MEDevice Silicon Valley 2026 conference profile is our canonical exhibitor planning resource, it's the page we built first when the rebrand happened, and we keep it updated with estimated cost ranges, audience composition, and Informa Markets contact details.

Why the BIOMEDevice Silicon Valley 2026 Event Matters

For exhibitors and attendees who fit, the case for this event comes down to three things:

1. Concentrated buyer access in the Bay Area medtech ecosystem. Roughly 40% purchasing-authority concentration in a 1,200-attendee event means your conversion math is fundamentally different than at a 7,000-attendee show. You can realistically work the full floor, get to every exhibitor that matters, and have meaningful conversations rather than 60-second exchanges.
2. Innovation-skewed audience. The Santa Clara crowd is heavier on AI medtech, software-as-a-medical-device, connected health, and startup-side innovation than the broader MD&M shows. If your product or service is targeting those segments, this is the show with the highest density of buyers and partners.
3. Two-day, single-venue, free-expo format. Low travel burden, low entry cost for prospects (free expo with pre-registration), and a tight enough show that you don't need a four-person booth team. Two strong people working a 10×10 booth can run the show.

The case against is just as clear. If your product is high-volume contract manufacturing for established OEM programs, MD&M West is much louder and bigger. If your buyers are clinicians, health system supply chain, or hospital procurement, this isn't your audience. And if your team is already stretched across MD&M West, MD&M East, RSNA, and FIME, adding Santa Clara may not pencil out.

For exhibitors weighing the spend, our medical device trade show ROI guide walks through the math we run with clients before they commit to a booth, and our pre-conference email campaigns playbook covers the outreach sequence that turns booth slots into booked meetings.

How to Get Ready for the 2026 Event

If you've decided to attend or exhibit, the practical setup is short:

• Pre-register at medevicesiliconvalley.com at least four weeks before November 18 to lock in the free expo pass and skip the on-site badge line.
• Book hotels by mid-September. The Hyatt Regency Santa Clara is connected to the Convention Center by covered walkway; the Avatar, Hilton, and Embassy Suites are all within a 10-minute walk and fill 4 to 6 weeks before the show.
• Pull the exhibitor list two weeks out and tag the 10 to 15 vendors you most want to meet. Send a short LinkedIn message to a named person at each booth.
• If you're exhibiting, finalize booth design, badge staffing, and lead retrieval at least 30 days out. Informa's deadlines for show services (electrical, A/V, internet) tighten and prices escalate inside that window.
• Build your follow-up sequence before you fly. Most of the ROI from a two-day show is decided in the 14 days after, not during. Have your CRM workflow, email templates, and outreach cadence ready before you walk into the hall.

For day-by-day logistics, flights, parking, transit, networking, hour-by-hour playbook, our BIOMEDevice Silicon Valley 2026 Santa Clara attendee guide is the companion piece to this overview. And if you want the deeper context on what the rebrand means for past attendees, the BIOMEDevice Silicon Valley 2026 Santa Clara rebrand explainer covers what carried over and what didn't.